Gelonghui, April 19 | Yibai Pharmaceutical (600594.SH) is now down 7% to 3.85 yuan. The cumulative decline over the past 6 days has exceeded 20%, with a total market value of 3.05 billion yuan. According to news, the company announced yesterday after the market that it achieved operating income of 573 million yuan in the first quarter, down 16.26% year on year; net profit to mother was -68 million yuan, changing from profit to loss year on year. Furthermore, companies and executives were penalized for production management issues.
A股异动 | 首季亏损，益佰制药跌7%
A-share changes | First quarter losses, Yibai Pharmaceuticals fell 7%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.